BRCA2 and hypoparathyroidism-retardation-dysmorphism syndrome: The fact that we did not observe the induction of mCCL5 in our Brca2 knockout mouse experiments may be explained by epigenetic silencing described in the ID8 model and human HRD ovarian cancer cells [39, 40].